Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
acamprosate (campral) (1 trial)
cyclophosphamide (cytoxan) (2 trials)
docetaxel (taxotere) (2 trials)
epirubicin (ellence) (2 trials)
fluorouracil (efudex) (1 trial)
naltrexone (revia) (1 trial)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)
bioconjugate pneumococcal vaccine (1 trial)
Alcoholism (Phase 4)
Breast Neoplasms (Phase 3)
Pneumonia (Phase 1)
Pneumonia, Bacterial (Phase 1)
Pneumonia, Pneumococcal (Phase 1)
Trials (4 total)
Trial APIs (8 total)